Sanofi (SAN):企業の財務・戦略的SWOT分析

◆英語タイトル:Sanofi (SAN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1655
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:86
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanofi (SAN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sanofi is a healthcare company that discovers, develops, manufactures and markets a wide range of medicines and vaccines. Its portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and other products. The company also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women’s health; and vitamins, minerals and supplements. Sanofi’s R&D efforts focus on advancing combination drugs to increase the effectiveness of treatments and on advancing the formulation of new biologics to produce medicines with precision. It has operations across Europe, the Americas, Asia-Pacific, Africa and the Middle East. Sanofi is headquartered in Paris, France.

Sanofi Key Recent Developments

Apr 24,2020 Sanofi at forefront of fight against COVID-19 in Q1 2020
Apr 17,2020 Sanofi, Luminostics to develop self-testing solution for Covid-19
Apr 14,2020 Sanofi and GSK partner to develop Covid-19 vaccine
Apr 14,2020 Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sanofi – Key Facts
Sanofi – Key Employees
Sanofi – Key Employee Biographies
Sanofi – Major Products and Services
Sanofi – History
Sanofi – Company Statement
Sanofi – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Sanofi – Business Description
Business Segment: Consumer Health
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Business Segment: Vaccines
Overview
Performance
Key Stats
Geographical Segment: Emerging Markets
Target Markets
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Sanofi – Corporate Strategy
Sanofi – SWOT Analysis
SWOT Analysis – Overview
Sanofi – Strengths
Sanofi – Weaknesses
Sanofi – Opportunities
Sanofi – Threats
Sanofi – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sanofi, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 24, 2020: Sanofi at forefront of fight against COVID-19 in Q1 2020
Apr 17, 2020: Sanofi, Luminostics to develop self-testing solution for Covid-19
Apr 14, 2020: Sanofi and GSK partner to develop Covid-19 vaccine
Apr 14, 2020: Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
Apr 09, 2020: Sanofi receives 2020 International Society for Pharmaceutical Engineering (ISPE) Facility of the Year Award
Mar 27, 2020: Sanofi and Translate Bio to develop mRNA vaccine for Covid-19
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
Mar 23, 2020: Feinstein Institutes announces partnerships for Covid-19 trials
Mar 04, 2020: Sanofi’s Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sanofi, Key Facts
Sanofi, Key Employees
Sanofi, Key Employee Biographies
Sanofi, Major Products and Services
Sanofi, History
Sanofi, Subsidiaries
Sanofi, Joint Venture
Sanofi, Key Competitors
Sanofi, Ratios based on current share price
Sanofi, Annual Ratios
Sanofi, Annual Ratios (Cont...1)
Sanofi, Annual Ratios (Cont...2)
Sanofi, Interim Ratios
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sanofi, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sanofi, Performance Chart (2015 - 2019)
Sanofi, Ratio Charts
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Sanofi (SAN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MicroVention Inc:製品パイプライン分析
    Summary MicroVention Inc (MicroVention), a subsidiary of Terumo Corp is a medical device company that develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. The company offers products such as platinum coils, hydrogel coils, delivery and det …
  • Haitong Securities Co., Ltd.:企業のM&A・事業提携・投資動向
    Haitong Securities Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Haitong Securities Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Taiwan Mobile Co., Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Mobile Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Mobile Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Telekom Austria AG:企業の戦略・SWOT・財務情報
    Telekom Austria AG - Strategy, SWOT and Corporate Finance Report Summary Telekom Austria AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Glomac Berhad:企業の戦略・SWOT・財務情報
    Glomac Berhad - Strategy, SWOT and Corporate Finance Report Summary Glomac Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Perenco Holdings-石油・ガス分野:企業M&A・提携分析
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • Deloitte Touche Tohmatsu Limited:企業の戦略・SWOT・財務分析
    Deloitte Touche Tohmatsu Limited - Strategy, SWOT and Corporate Finance Report Summary Deloitte Touche Tohmatsu Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Hilcorp Energy Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Hilcorp Energy Co (Hilcorp) is an oil and natural gas exploration and production company. The company acquires and exploits conventional assets. It offers services such as employee services, engineering and geological programs and operational programs. Hilcorp has operations in the gulf coas …
  • Unilever Ghana Ltd.:企業の戦略・SWOT・財務分析
    Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report Summary Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TechnoPhage SA:製薬・医療:M&Aディール及び事業提携情報
    Summary TechnoPhage SA (TechnoPhage) is a biopharmaceutical company that offers contract research and development of new molecules. The company conducts its research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development servi …
  • Adient Plc (ADNT):企業の財務・戦略的SWOT分析
    Adient Plc (ADNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tsakos Energy Navigation Limited:企業の戦略・SWOT・財務分析
    Tsakos Energy Navigation Limited - Strategy, SWOT and Corporate Finance Report Summary Tsakos Energy Navigation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sunwin Stevia International Inc (SUWN):企業の財務・戦略的SWOT分析
    Sunwin Stevia International Inc (SUWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Burlington Northern Santa Fe, LLC:企業の戦略・SWOT・財務分析
    Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report Summary Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The PNC Financial Services Group Inc:企業のM&A・事業提携・投資動向
    The PNC Financial Services Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The PNC Financial Services Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • B. Braun Melsungen AG:戦略・SWOT・企業財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NCSG Crane & Heavy Haul Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary NCSG Crane & Heavy Haul Corp (NCSG), formerly NC Services Group Ltd is a construction equipment provider that offers mobile crane rental and heavy haul services. The company’s services comprise operated and maintained crane services, bare rental cranes, contract lifting, heavy hauling, on-si …
  • IMI plc:企業の戦略・SWOT・財務情報
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Alfa SAB de CV (ALFAA):企業の財務・戦略的SWOT分析
    Alfa SAB de CV (ALFAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆